The ACCORD study investigators have published the results of an extended follow-up of the trial, focused on patients with type 2 diabetes mellitus who had been initially assigned to different intensities of glucose control. These data add to existing knowledge on the benefits of glycemic control in this patient population.
- Sophia Zoungas
- Mark Woodward